You will learn when to make the transition, how to dose semaglutide based on your current tirzepatide dose, what side effects to expect, and how to maintain your weight loss results during the changeover
Medicaid coverage for weight loss medications, including GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Zepbound), varies dramatically from state to state
Glycemic control appears similar between the two peptides
For many people adopting the practice, the goal is to curb hunger just enough to make a weight-loss regimen easier to sustain
Some studies have suggested that brain regions with a high degree of functional connectivity are energy efficient and can minimize consumption of glucose [27, 51, 52]
References: Pi-Sunyer, X., Astrup, A., Fujioka, K., et al